{
    "Trade/Device Name(s)": [
        "Evolution\u2122 Blood Glucose Test System",
        "Evolution\u2122 Blood Glucose Testing System",
        "Evolution\u2122 Monitor",
        "Evolution\u2122 Test strip",
        "EvolutionT Blood Glucose Test"
    ],
    "Submitter Information": "HMD Biomedical LLC",
    "510(k) Number": "K072369",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021819"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "March 10, 2008",
    "Summary Letter Received Date": "March 11, 2008",
    "Submission Date": "March 19, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Glucose Oxidase Single (specified) analyte controls"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Evolution\u2122 Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test strip",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for HMD Evolution Blood Glucose Test System for quantitative measurement of glucose in whole blood using electrochemical detection.",
    "Indications for Use Summary": "For quantitative measurement of glucose in whole blood from various sites (fingertip, palm, hand, arm, forearm, calf, thigh) by diabetic patients or healthcare professionals as an aid in diabetes management; not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}